Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers

Psychopharmacology

Volumn 166, Issue 3, 2003, Pages 221-227

  Patkar, Ashwin A ^a   Gopalakrishnan, Raman ^a   Berrettini, Wade H ^b   Weinstein, Stephen P ^a   Vergare, Michael J ^a   Leone, Frank T ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Nicotine; Serotonin; Serotonin transporter; Smoking; Tobacco

Indexed keywords

NICOTINE; PAROXETINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; MALE; NEGRO; PRIORITY JOURNAL; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM; SMOKING; SMOKING CESSATION; THROMBOCYTE; TOBACCO;

EID: 0037349011     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-002-1353-2     Document Type: Article

References (48)

1. Anthenelli RM, Maxwell RA (2000) Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls. Alcohol Clin Exp Res 24:987-995
2. Arinami T, Obtsuki T, Yamakawa-Kobayashi K, Amemiya H, Fujiwars H, Kawata KI, Ishiguro H, Hamaguchi H (1999) A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 81:853-856
3. Beck AT, Steer RA (1987) Beck Depression Inventory. Psychological Corporation, Harcourt, Brace, Jovanovich, San Antonio, Texas
4. Benwell M, Balfour D (1982) Effects of nicotine administration on the uptake and biosynthesis of 5-HT in rat brain synaptosomes. Eur J Pharmacol 84:71-77
5. Berlin I, Said S, Spreux-Varoquaux O, Olivare R, Launay JM, Puech AJ (1995) Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 38:756-61
6. Blakely RD, Ramamoorthy S, Qian Y, Schroeter S, Bradley CC (1997) Regulation of antidepressant-sensitive serotonin transporters. In: Reith MEA (ed) Neurotransmitter transporters: structure, function, and regulation. Humana Press, New Jersey, pp 29-72
7. Buss AH, Durkee A (1957) An inventory for assessing different kinds of hostility. J Consult Psychol 21:343-348
8. Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C (1997) The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses. Biol Psychiatry 41:1071-1086
9. Castrigiovanni P, DiMuro A, Marazzati D (1995) Imipramine binding as a predictor of fluoxetine response in depressed patients. Neuropsychobiology 31:64-67
10. Coccaro EF, Kavoussi RJ, Sheline YL, Lish JD, Csernansky JG (1996) Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch Gen Psychiatry 53:531-536
11. Corash L, Costa JL, Shafer B, Donlon JA, Murphy D (1984) Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 64:185-193
12. Covey LS, Glassman AH, Stetner F, Rivelli S, Stage K (2002) A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. Am J Psychiatry 159:1731-1737
13. Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908
14. Da Prada M, Cesura AM, Launay JM, Richards JG (1988) Platelets as models for neurons? Experientia 44:115-126
15. Etter JF, Perneger TV (2001) Measurement of self reported active exposure to cigarette smoke. J Epidemiol Commun Health 55:674-680
16. Etter JF, Duc TV, Perneger TV (1999) Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction 94:269-281
17. Fagerstrom KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 2:235-241
18. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV disorders (SCID-IV). American Psychiatric Association, Washington D.C.
19. Fowler J, Volkow N, Wang G, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf A, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase in the brains of smokers. Nature 379:733-736
20. Graham D, Langer SZ (1992) Advances in sodium-ion coupled biogenic amine transporters. Life Sci 51:631-645
21. Greenberg BD, Tolliver TJ, Huang S, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83-87
22. Harrison AA, Liem YT, Markou A (2001) Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats. Neuropsychopharmacology 25:55-71
23. Heatherton TF, Kozlowski LT, Frecker RC (1991) The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119-1127
24. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624
25. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, Mizes JS, Seagraves KA, Kristeller JL, Xu W (1999) Antidepressant pharmacotherapy may help some cigarette smokers more than others. J Consult Clin Psychol 67:547-554
26. Ishikawa H, Ohtsuki T, Ishiguro H, Yamakawa-Kobayashi K, Endo K, Lin Y, Yanagi H, Tsuchiya S, Kawata K, Hamaguchi H, Arinami T (1999) Association between serotonin transporter gene polymorphism and smoking among Japanese males. Cancer Epidemiol Biomarkers Prev 8:831-833
27. Killen JD, Fortmann SP, Stephen P, Schatzberg AF, Hayward C, Sussman L, Rothman M, Strusberg L, Varady A (2000) Nicotine patch and paroxetine for smoking cessation [article]. J Consult Clin Psychol 68:883-889
28. Lesch KP, Wolozin BL, Murphy DL, Reiderer P (1993) Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 60:2319-2322
29. Linnoila VM, Virkunnen M (1992) Aggression, suicidality, and serotonin. J Clin Psychiatry 53:46-51
30. Lowry O, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
31. Macedo T, Ribeiro CA, Cotrim D, Tavares P, Morgadinho MT, Caramona M, Vicente MT, Rodriques L, Cardoso MG, Keating ML (1995) Catecholamine and MHPG plasma levels, platelet levels, platelet MAO activity, and 3H-imipramine binding in heroin and cocaine addicts. Mol Neurobiol 11:21-29
32. Maguire K, Tuckwell V, Pererira A, Dean B, Singh B (1993) Significant correlation between 14C-5-HT uptake and 3H-paroxetine binding to platelets from healthy volunteers. Biol Psychiatry 34:356-360
33. Maguire KP, Norman TR, Apostolopoulos M, Judd FK, Burrows GD (1995) Platelet [3H] paroxetine binding in panic disorder. J Affect Disord 33:117-122
34. Mendez-Alvarez E, Soto-Otero R, Sanchez-Sellero I, Lopez-Rivadulla M, Lamas M (1997) Inhibition of brain monoamine oxidase activity by adducts of 1,2,3,4-tetraishydroisoquinoline with components of cigarette smoke. Life Sci 60:1719-1727
35. Niaura R, Spring B, Borrelli B, Hedeker D, Goldstein MG, Keuthen N, Depue J, Kristeller J, Ockene J, Prochazka A, Chiles JA, Abrams DB (2002). Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. J Consult Clin Psychol 70:887-896
36. Olausson P, Engel JA, Soderpalm B (2002) Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol Biochem Behav 71:757-771
37. Ozaki N, Rosenthal NE, Mazzola P, Chiveh CC, Hardin T, Garcia-Borreguero D, Schwartz PJ, Turner E, Oren DA, Murphy DL (1994) Platelet [3H]paroxetine binding, 5-HT stimulated Ca2+ response, and 5-HT content in winter seasonal affective disorder. Biol Psychiatry 136:458-466
38. Patkar AA, Naik P, Mardsen CA, McLean PC, Kendall DA, Al-Chalabi T (1995) Platelet [3H]-binding in type I and type II alcoholism. Hum Psychopharmacol 10:1-6
39. Patkar AA, Gottheil E, Berrettini WH, Hill KP, Thornton CC, Weinstein SP (2003) Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression and craving among African-American cocaine abusers. Am J Addict (in press)
40. Pomerleau CS, Pomerleau OF, Majchrzak MJ, Kloska DD, Malakuti R (1990) Relationship between nicotine tolerance questionnaire scores and plasma cotinine. Addict Behav 15:73-80
41. Rausch JL, Fefferman M, Ladisich-Rogers DG, Menard M (1989) Effect of nicotine on human blood platelet serotonin uptake and efflux. Prog Neuropsychopharmacol Biol Psychiatry 13:907-916
42. Reuben M, Clarke PB (2000) Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology 39:290-299
43. Ribeiro EB, Bettiker RL, Bogdanov M, Wurtman RJ (1993) Effects of systemic nicotine on serotonin release in rat brain. Brain Res 621:311-318
44. Seth P, Cheeta S, Tucci S, File SE (2002) Nicotinic -serotonergic interactions in brain and behavior. Pharmacol Biochem Behav 71:795-805
45. Sheline YI, Black KJ, Bardgett ME, Csernansky JG (1005) Platelet binding characteristics distinguish placebo responders from nonresponders. Neuropsychopharmacology 12:315-322
46. Strachan AT, Maughan RJ (1998) Platelet serotonin transporter density and related parameters in endurance trained and sedentary male subjects. Acta Physiol Scand 163:165-171
47. Wagenknecht LE, Cutter GR, Haley NJ, Sidney S, Manolio TA, Hughes GH, Jacobs DR (1990) Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health 80:1053-1056
48. Xu Z, Seidler FJ, All SF, Slikker W, Slotkin TA (2001) Fetal and adolescent nicotine administration: effects on CNS. Brain Res 914:166-178